Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters
Thu, 06/6/24 - 11:34 am
Tags:
Novartis, Roche, Genentech, Italy, antitrust, Biogen, Samsung Bioepis, Byooviz
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
Tags:
R&D, Novartis, Argo Biopharmaceutical, Roche, MOMA Therapeutics, Boehringer Ingelheim, Suzhou Ribo Life Science, Eli Lilly, Isomorphic Labs, Merus, Gilead Sciences, Novo Nordisk, Neomorph, AbbVie, Umoja Biopharma, Merck KGaA, Caris Life Sciences, Voyager Therapeutics
Novartis sues Maryland over law mandating discounts for hospitals' outside pharmacies
Reuters
Sun, 06/2/24 - 02:43 pm
Tags:
Novartis, Maryland, legal, 340B, drug discounts
Novartis study points to larger role for targeted leukemia drug
BioPharma Dive
Fri, 05/31/24 - 10:50 am
Tags:
Novartis, Scemblix, ASCO 2024, clinical trials, CML
Novartis cues up filings for remibrutinib in chronic hives
Pharmaphorum
Fri, 05/31/24 - 10:47 am
Tags:
Novartis, remibrutinib, chronic hives, clinical trials
Novartis brings augmented reality tech to ASCO to simulate leukemia patient experience
Fierce Pharma
Thu, 05/30/24 - 11:32 am
Tags:
Novartis, ASCO 2024, augmented reality, patients, CML
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins
BioSpace
Tue, 05/28/24 - 10:47 am
Tags:
Novartis, kidney disease, atrasentan, IgA nephropathy, Fabhalta
Novartis Meets Offer Conditions To Buy MorphoSys In EUR 68/shr Cash Deal
NASDAQ
Fri, 05/17/24 - 11:24 am
Tags:
Novartis, MorphoSys, M&A
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Tags:
Big Pharma, Eli Lilly, Mounjaro, Novo Nordisk, Wegovy, JNJ, Tecvayli, Merck, Vaxneuvance, AbbVie, Qulipta, AstraZeneca, Saphnelo, Novartis, Leqvio, Roche, Genentech, Vabysmo, Amgen, Evenity, Pfizer, Vyndaqel
Why selling to Novartis made sense for Mariana
BioPharma Dive
Sun, 05/5/24 - 11:37 pm
Tags:
Novartis, Mariana, M&A, JPMHC 2024
Novartis further entrenches into radiopharma with $1B Mariana buy
Fierce Biotech
Thu, 05/2/24 - 11:41 am
Tags:
Novartis, M&A, Mariana Oncology, radiopharmaceuticals
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech
Tue, 04/30/24 - 08:27 am
Tags:
Novartis, radioligand, radiopharmaceuticals, PeptiDream, peptide-drug conjugate
Novartis names ex-BMS CEO Caforio as chair amid strong Q1
Pharmaphorum
Tue, 04/23/24 - 10:29 am
Tags:
Novartis, earnings, Giovanni Caforio, Bristol Myers Squibb
Novartis touts surrogate endpoint win, nabs priority review for Fabhalta in IgAN
Fierce Pharma
Mon, 04/15/24 - 09:32 pm
Tags:
Novartis, Fabhalta, IgAN, priority review, FDA
Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing
Fierce Biotech
Fri, 04/12/24 - 11:23 am
Tags:
Novartis, MorphoSys, pelabresib, myelofibrosis, M&A, BET inhibitor
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
BioSpace
Thu, 04/11/24 - 10:22 pm
Tags:
biotech, layoffs, Genentech, Sanofi, Novartis
Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader
Fierce Biotech
Thu, 04/11/24 - 11:56 am
Tags:
Novartis, Arvinas, protein degradation, prostate cancer
Novartis begins tender offer for cancer-focused MorphoSys
Reuters
Thu, 04/11/24 - 11:54 am
Tags:
Novartis, M&A, cancer, MorphoSys
Novartis pauses enrollment in some Kisqali trials to fix manufacturing
BioPharma Dive
Wed, 04/10/24 - 05:28 pm
Tags:
Novartis, Kisqali, drug manufacturing, breast cancer, clinical trials
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
Tags:
oncology, M&A, AbbVie, Immunogen, Bristol Myers Squibb, Mirati Therapeutics, RayzeBio, Novartis, MorphoSys, AstraZeneca, Fusion Pharmaceuticals, JNJ, Ambrx, Gracell

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.